OVATION Pharmaceuticals, Inc. provides innovative medicines to people with unmet medical needs in more than 85 countries.  Innovation is in everything we do: from our unique approach to developing and sustaining lifesaving products for severely ill patients, to ensuring these medicines are always available for those who need them.  

By concentrating on investigational and approved drugs for focused patient populations where there is a significant need for treatment – including conditions like Lennox-Gastaut syndrome, Wilms' tumor and acute intermittent porphyria, as well as broader epilepsies and cancers – we fill an important void in the pharmaceutical industry. While not “blockbusters” by industry standards, our medicines take on blockbuster significance for certain patient populations where treatment options have been limited, but are no less essential.   

OVATION's growing portfolio of pharmaceutical products, combined with our strong success at developing and bringing new therapies to market, ensures that we continually deliver on our promise of improving the lives of patients with critical – and unmet – medical needs.